Literature DB >> 4091526

Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.

A Bouvet, A C Cremieux, A Contrepois, J M Vallois, C Lamesch, C Carbon.   

Abstract

Six different antibiotic treatment regimens were compared for efficacy in rabbits with endocarditis induced by inoculation with a nutritionally variant strain of streptococcus. Seven untreated animals, sacrificed at day 11, had vegetations containing 8.89 +/- 1.35 log10 CFU/g, none of which was sterile. The vegetations from the rabbits in all treated groups had bacterial titers significantly lower than those of the controls (P less than 0.001). Vegetations from penicillin-treated animals averaged 5.14 +/- 1.00 log CFU/g, and no vegetations were sterile. Treatment with penicillin plus gentamicin or amikacin was more effective than treatment with penicillin alone, resulting in 3.99 +/- 0.94 log CFU/g of vegetation and sterile lesions in 5 of 12 animals. Treatment with vancomycin alone was as least as efficient as that with penicillin plus an aminoglycoside, resulting in an average of 3.33 +/- 0.96 log CFU/g of vegetation and sterile lesions in five of eight animals. Treatment with vancomycin plus an aminoglycoside was not superior to treatment with vancomycin alone, resulting in an average of 3.68 +/- 1.37 log CFU/g of vegetation and sterile lesions in 8 of 13 animals. These in vivo results correlated poorly with the in vitro susceptibility of the strain to the various antibiotics, as measured by the time-kill method. These results support the current practice of using vancomycin as alternative therapy when a penicillin-aminoglycoside combination is ineffective or contraindicated in patients with endocarditis caused by nutritionally variant streptococci.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091526      PMCID: PMC176343          DOI: 10.1128/AAC.28.5.607

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Antimicrobial therapy of vitamin B6-dependent streptococcal endocarditis.

Authors:  R B Carey; B D Brause; R B Roberts
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

2.  Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants.

Authors:  P Cayeux; J F Acar; Y A Chabbert
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

3.  In vitro antimicrobial inhibition patterns of nutritionally variant streptococci.

Authors:  R C Cooksey; J M Swenson
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

4.  Vitamin B6-dependent Streptococcus mitior (mitis) isolated from patients with systemic infections.

Authors:  R B Carey; K C Gross; R B Roberts
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

5.  Serum aminoglycoside assay by enzyme-mediated immunoassay (EMIT): correlation with radioimmunoassay, microbiological assays.

Authors:  L O White; L M Scammell; D S Reeves
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore.

Authors:  A Bouvet; I van de Rijn; M McCarty
Journal:  J Bacteriol       Date:  1981-06       Impact factor: 3.490

7.  Nutritionally deficient streptococci: electron microscopic study of 14 strains isolated in bacterial endocarditis.

Authors:  A Bouvet; A Ryter; C Fréhel; J F Acar
Journal:  Ann Microbiol (Paris)       Date:  1980 Sep-Oct

8.  Antimicrobial susceptibilities of nutritionally variant streptococci.

Authors:  J F Gephart; J A Washington
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

9.  Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci.

Authors:  R B Roberts; A G Krieger; N L Schiller; K C Gross
Journal:  Rev Infect Dis       Date:  1979 Nov-Dec

10.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
View more
  15 in total

Review 1.  Nutritionally variant streptococci.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Characterization of emb, a gene encoding the major adhesin of Streptococcus defectivus.

Authors:  R Manganelli; I van de Rijn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.

Authors:  J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.

Authors:  V Joly; B Pangon; J M Vallois; L Abel; N Brion; A Bure; N P Chau; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 5.  Endocarditis due to rare and fastidious bacteria.

Authors:  P Brouqui; D Raoult
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.

Authors:  B Fantin; B Pangon; G Potel; J M Vallois; F Caron; A Bure; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

7.  Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.

Authors:  A C Cremieux; A Saleh-Mghir; J M Vallois; B Maziere; M Muffat-Joly; C Devine; A Bouvet; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

8.  Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.

Authors:  D P Nicolau; C D Freeman; C H Nightingale; C J Coe; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.

Authors:  B Pangon; V Joly; J M Vallois; L Abel; A Buré; N Brion; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

10.  Evaluation of E test as a rapid method for determining MICs for nutritionally variant streptococci.

Authors:  C P Douglas; S Siarakas; T Gottlieb
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.